Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Settles Seroquel Suits For A Third Of What Lilly Paid For Zyprexa

Executive Summary

In deciding to settle rather than continue to litigate Seroquel (quetiapine) product liability claims, AstraZeneca is following the path Lilly took in resolving suits over its antipsychotic Zyprexa (olanzapine). But the financial burden won't be as heavy for AstraZeneca

You may also be interested in...



AstraZeneca Faces Government Probe Of Synagis Sales And Marketing

The investigation comes one year after the company reached a settlement with the DoJ over its Seroquel marketing and as it faces probe over its relationship with Medco.

AstraZeneca Faces Government Probe Of Synagis Sales And Marketing

The investigation comes one year after the company reached a settlement with the DoJ over its Seroquel marketing and as it faces probe over its relationship with Medco.

Seroquel XR Remission Claims Challenged By FDA As AstraZeneca Puts Lawsuits To Rest

"Remission" has no regulatory definition in major depressive disorder, FDA says in letter citing a sales rep aid left with doctors.

Related Content

Topics

UsernamePublicRestriction

Register

PS052518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel